These findings are validated by other studies showing marked inhibition of gastric, breast, and cervical tumor migration and invasion by abrogation of ARF6, NEDD9 and MT1-MMP expression [14, 26, 39]. The gene discussed is ARF6; the disease is uterine cervix neoplasm.